B Cell Lymphoma Trials

Compare and research clinical trials and research studies related to B Cell Lymphoma. Start researching B Cell Lymphoma clinical trials below:


Improvement of Therapy of Elderly Patients Witch CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

This study is currently recruiting participants. Verified December 2011 by University Hospital, Saarland First Received on November 18, 2011.   …

Continue reading about Clinical Trial Improvement of Therapy of Elderly Patients Witch CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas

This study is currently recruiting participants. Verified August 2012 by Thomas Jefferson University First Received on September 26, 2011.   …

Continue reading about Clinical Trial Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas

Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL

This study is currently recruiting participants. Verified November 2010 by Hackensack University Medical Center First Received on November 15, 2010. &n…

Continue reading about Clinical Trial Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL

Tailoring Treatment for B Cell Non-hodgkin’s Lymphoma Based on PET Scan Results Mid Treatment

This study is currently recruiting participants. Verified September 2010 by British Columbia Cancer Agency First Received on May 9, 2006.   …

Continue reading about Clinical Trial Tailoring Treatment for B Cell Non-hodgkin’s Lymphoma Based on PET Scan Results Mid Treatment

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

This study is currently recruiting participants. Verified June 2012 by Celldex Therapeutics First Received on October 12, 2011.   Last U…

Continue reading about Clinical Trial A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

This study is currently recruiting participants. Verified March 2012 by Emory University First Received on February 11, 2008.   Last Upd…

Continue reading about Clinical Trial A Phase I/II Trial of VR-CHOP in Lymphoma Patients

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma

This study is currently recruiting participants. Verified July 2011 by Seoul National University Hospital First Received on August 3, 2010.   …

Continue reading about Clinical Trial Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma

An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

This study is currently recruiting participants. Verified August 2012 by Hoffmann-La Roche First Received on April 20, 2011.   Last Upda…

Continue reading about Clinical Trial An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

This study is currently recruiting participants. Verified May 2012 by National Institutes of Health Clinical Center (CC) First Received on December 11,…

Continue reading about Clinical Trial Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom’s Macroglobulinemia

This study is currently recruiting participants. Verified May 2011 by Avila Therapeutics First Received on May 10, 2011.   Last Updated …

Continue reading about Clinical Trial Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom’s Macroglobulinemia